Sunpointe LLC bought a new stake in MetLife, Inc. (NYSE:MET - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,333 shares of the financial services provider's stock, valued at approximately $273,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. MeadowBrook Investment Advisors LLC raised its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider's stock worth $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider's stock worth $27,000 after buying an additional 186 shares during the last quarter. Peterson Financial Group Inc. purchased a new position in MetLife during the 3rd quarter worth approximately $30,000. Sierra Ocean LLC acquired a new stake in MetLife during the 4th quarter valued at approximately $32,000. Finally, Retirement Wealth Solutions LLC purchased a new stake in shares of MetLife in the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 94.99% of the company's stock.
MetLife Price Performance
Shares of NYSE MET traded up $0.59 during trading on Monday, hitting $81.60. The company had a trading volume of 1,456,691 shares, compared to its average volume of 3,552,127. The firm has a market capitalization of $56.50 billion, a price-to-earnings ratio of 13.67, a price-to-earnings-growth ratio of 0.65 and a beta of 1.07. The stock has a fifty day simple moving average of $83.41 and a two-hundred day simple moving average of $81.53. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a fifty-two week low of $67.30 and a fifty-two week high of $89.05.
MetLife (NYSE:MET - Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. On average, research analysts expect that MetLife, Inc. will post 9.65 earnings per share for the current year.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio is currently 36.52%.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. BMO Capital Markets assumed coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 target price for the company. Wells Fargo & Company upped their target price on MetLife from $92.00 to $97.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 19th. Barclays dropped their target price on MetLife from $96.00 to $95.00 and set an "overweight" rating on the stock in a report on Friday, February 7th. TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a report on Wednesday, November 27th. Finally, JPMorgan Chase & Co. raised their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research note on Tuesday, January 7th. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, MetLife has an average rating of "Moderate Buy" and an average price target of $92.58.
Read Our Latest Stock Report on MET
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
